Abstract
The prevalence of asthma has been increasing, especially in children (1). An article reported that in Canada one in three patients would have a physician diagnosis of asthma in their lifetime (2). Work in the field of asthma this year included evaluation of new therapies, reevaluation of the benefits and risks of available therapy, and research into clinical and biomarker patterns that might allow us to differentiate among different phenotypes of asthma. There were also reports on advances in the understanding of potential immune, cellular, and biochemical mechanisms that might contribute to asthma pathobiology, work in defining genetic contributors to asthma, and elucidation of environmental factors that can influence the development or expression of the disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: American Journal of Respiratory and Critical Care Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
